Miscellaneous Immune Disorders Archives - MPR

Miscellaneous Immune Disorders

Eosinophil cells

Mepolizumab Reduces Flares in Patients With Hypereosinophilic Syndrome

GlaxoSmithKline announced positive results from the pivotal phase 3 study of mepolizumab in the treatment of patients with hypereosinophilic syndrome (HES). HES is a rare group of inflammatory disorders characterized by persistent eosinophilia that can potentially lead to inflammation, organ damage, and possibly death if left untreated.  The 32-week, double-blind, placebo-controlled phase 3 study evaluated…